InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Herman James L, Responsable de la Conformité. Director active across 1 companies, notably Cumberland Pharmaceuticals INC. Aggregated, 3 disclosures have been published. The latest transaction was filed on 20 March 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is free.
Declarations3 total
€3,1601,280 shares@ €2.46860.0039% mcap18.6% of flow
Common Stock
SEC:0001209191-22-026142:0·
€6,9262,560 shares@ €2.70550.0085% mcap40.7% of flow
Common Stock
SEC:0001209191-21-039926:0·
€6,9262,560 shares@ €2.70550.0085% mcap100.0% of flow
Common Stock
SEC:0001209191-21-039926·
3 of 3 declarations
About Herman James L
James L. Herman is the Vice President and Chief Compliance Officer of Cumberland Pharmaceuticals Inc. In this role, he oversees compliance affairs and ensures that the company adheres to regulatory requirements. Herman brings expertise in regulatory compliance and risk management, contributing to the protection of the company's interests and its stakeholders. His commitment to transparency and accountability is essential to maintain investor confidence.
